Health Improvement Strategy
Overdose Response Training
https://mygarrettcounty.com/groups/overdose-response-training/
Goal:
Reduce and/or prevent opioid overdose deaths in Garrett County.
Strategy Description:
Reduce and/or prevent opioid overdose deaths in Garrett County through distributing naloxone in the community and educating the community on administration and follow-up steps. To accomplish this the group will.
Advertise the Overdose Response Training (ORT) classes to the community.
Provide classes in a variety of locations and on demand.
Distribute naloxone after the completion of training.
Work with other organisations to distribute naloxone in high risk settings.
Level of Change:
Programs
Primary Focus Area:
Behavioral Health: including Substance Abuse and Mental Health
Data Category Tag:
GCHD Behavioral Health
Strategic Planning Alignment:
Estimated Implementation Date:
2017-08-21
Estimated Completion Date:
2022-12-31
Estimated Ease of Implementation:
Easy
Estimated Cost of Implementation:
Low
Potential Community Benefit:
High
Research:
According to the results of a recent systematic review published in the Annals of Internal Medicine, 2 mg/mL intranasal naloxone may have comparable efficacy and tolerability to intramuscular naloxone. After overdose reversal, the benefits of transport to a hospital remain unclear.
Researchers evaluated cohort studies and randomized trials that compared naloxone dosing, administration routes, and transport to a hospital after opioid overdose. Mortality, reversal of overdose, recurrence of overdose, and harms were the main outcomes assessed.
Higher-concentration intranasal naloxone (2 mg/mL) was shown to have similar efficacy to intramuscular naloxone (2 mg) in one trial. In another trial, lower-concentration intranasal naloxone (2 mg/5 mL) was associated with lower effectiveness but reduced risk for agitation compared with intramuscular naloxone.
https://bha.health.maryland.gov/NALOXONE/Pages/Naloxone.aspx
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753997/
https://www.clinicalpainadvisor.com/home/topics/opioid-addiction/efficacy-tolerability-of-intranasal-vs-intramuscular-naloxone-for-opioid-overdose/
